High expression of osteoglycin decreases the metastatic capability of mouse hepatocarcinoma Hca-F cells to lymph nodes

Acta Biochimica et Biophysica Sinica

Volumn 40, Issue 4, 2008, Pages 349-355

  Cui, Xiaonan ^a   Song, Bo ^a   Hou, Li ^a   Wei, Zhiyi ^a   Tang, Jianwu ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Neoplasm metastasis; Osteoglycin; Transfection

Indexed keywords

EUKARYOTA;

ANIMAL; ARTICLE; GENE EXPRESSION REGULATION; LIVER CELL CARCINOMA; LIVER TUMOR; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METABOLISM; METASTASIS; MOUSE; MOUSE STRAIN; TUMOR CELL LINE; UPREGULATION;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; LIVER NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED STRAINS; UP-REGULATION;

EID: 42449156277     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2008.00392.x     Document Type: Article

References (32)

1. Hocking AM, Shinomura T, McQuillan DJ. Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 1998, 17 : 1 19.
2. Kresse H, Schönherr E. Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 2001, 189 : 266 274.
3. Couchman JR, Chen L, Woods A. Syndecans and cell adhesion. Int Rev Cytol 2001, 207 : 113 150.
4. Wiberg C, Hedbom E, Khairullina A, Lamande SR, Oldberg A, Timpl R, Morgelin M et al. Biglycan and decorin bind close to the n-terminal region of the collagen VI triple helix. J Biol Chem 2001, 276 : 18947 18952.
5. Font B, Eichenberger D, Rosenberg LM. van der Rest M. Characterization of the interactions of type XII collagen with two small proteoglycans from fetal bovine tendon, decorin and fibromodulin. Matrix Biol 1996, 15 : 341 348.
6. Keene DR, San Antonio JD, Mayne R, McQuillan DJ, Sarris G, Santoro SA, Iozzo RV. Decorin binds near the C terminus of type I collagen. J Biol Chem 2000, 275 : 21801 21804.
7. Hildebrand A, Romarís M, Rasmussen LM, Heinegard D, Twardzik DR, Border WA, Ruoslahti E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 1994, 302 : 527 534.
8. Hausser H, Gröning A, Hasilik A, Schönherr E, Kresse H. Selective inactivity of TGF-β-decorin complexes. FEBS Lett 1994, 353 : 243 245.
9. Markmann A, Hausser H, Schönherr E, Kresse H. Influence of decorin expression on transforming growth factor-β-mediated collagen gel retraction and biglycan induction. Matrix Biol 2000, 19 : 631 636.
10. 2+ in A431 carcinoma cells. J Biol Chem 1998, 273 : 3121 3124.
11. Iozzo RV, Moscatello DK, McQuillan DJ, Eichstetter I. Decorin is a biological ligand for the epidermal growth factor receptor. J Biol Chem 1999, 274 : 4489 4492.
12. Santra M, Mann DM, Mercer EW, Skorski T, Calabretta B, Iozzo RV. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-depen-dent kinases. J Clin Invest 1997, 100 : 149 157.
13. Xaus J, Comalada M, Cardo M, Valledor AF, Celada A. Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27 (Kipl) and p21(Wafl). Blood 2001, 98 : 2124 2133.
14. De Luca A, Santra M, Baldi A, Giordano A, Iozzo RV. Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J Biol Chem 1996, 271 : 18961 18965.
15. Schönherr E, Levkau B, Schaefer L, Kresse H, Walsh K. Decorin-mediated signal transduction in endothelial cells. Involvement of Akt-protein kinase B in up-regulation of p21(WAF1-CIP1) but not p27(KIP1). J Biol Chem 2001, 276 : 40687 40692.
16. Schönherr E, O'Connell BC, Schittny J, Robenek H, Fastermann D, Fisher LW, Plenz G et al. Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. Eur J Cell Biol 1999, 78 : 44 55.
17. Iozzo RV, Chakrani F, Perrotti D, McQuillan DJ, Skorski T, Calabretta B, Eichstetter I. Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc Natl Acad Sci USA 1999, 96 : 3092 3097.
18. Ameye L, Young MF. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology 2002, 12 : 107 116.
19. Tasheva ES, Koester A, Paulsen AQ, Garrett AS, Boyle DL, Davidson HJ, Song M et al. Mimecan-osteoglycin-deficient mice have collagen fibril abnormalities. Mol Vis 2002, 8 : 407 415.
20. Plaas AH, West LA, Thonar EJ, Karcioglu ZA, Smith CJ, Klintworth GK, Hascall VC. Altered fine structures of corneal and skeletal keratan sulfate and chondroitin-dermatan sulfate in macu-lar corneal dystrophy. J Biol Chem 2001, 276 : 39788 39796.
21. Tasheva ES, Maki CG, Conrad AH, Conrad GW. Transcriptional activation of bovine mimecan by p53 through an intronic DNA-binding site. Biochim Biophys Acta 2001, 1517 : 333 338.
22. Tasheva ES. Analysis of the promoter region of human mimecan gene. Biochim Biophys Acta 2002, 1575 : 123 129.
23. Shanahan CM, Cary NR, Osbourn JK, Weissberg PL. Identification of osteoglycin as a component of the vascular matrix. Differential expression by vascular smooth muscle cells during neointima formation and in atherosclerotic plaques. Arterioscler Thromb Vasc Biol 1997, 17 : 2437 2447.
24. Tasheva ES, Funderburgh ML, McReynolds J, Funderburgh JL, Conrad GW. The bovine mimecan gene. Molecular cloning and characterization of two major RNA transcripts generated by alternative use of two splice acceptor sites in the third exon. J Biol Chem 1999, 274 : 18693 18701.
25. Tasheva ES, Conrad GW. Interferon-γ regulation of the human mimecan promoter. Mol Vis 2003, 30 : 277 287.
26. Chu H, Zhou H, Liu Y, Hu Y, Zhang J. Functional expression of CXC chemokine recepter-4 mediates the secretion of matrix metalloproteinases from mouse hepatocarcinoma cell lines with different lymphatic metastasis ability. Int J Biochem Cell Biol 2007, 39 : 197 205.
27. Zhou H, Jia L, Wang S, Wang H, Chu H, Hu Y, Cao J et al. Divergent expression and roles for caveolin-1 in mouse hepatocarcinoma cell lines with varying invasive ability. Biochem Biophys Res Commun 2006, 345 : 486 494.
28. Tian H, Li L, Liu X, Zhang Y. Antitumor effect of antisense ornithine decarboxylase adenovirus on human lung cancer cells. Acta Biochim Biophys Sin 2006, 38 : 410 416.
29. Zhang YK, Shen GF, Ru BG. Survival of human metallothionein-2 transplastomic chlamydomonas reinhardtii to ultraviolet B exposure. Acta Biochim Biophys Sin 2006, 38 : 187 193.
30. Fokas E, Engenhart-Cabillic R, Daniilidis K, Rose F, An HX. Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev 2007, 26 : 705 715.
31. Torng PL, Lee YC, Huang CY, Ye JH, Lin YS, Chu YW, Huang SC et al. Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma. Oncogene 2007, 22 Oct (Epub ahead of print).
32. Gravdal K, Halvorsen OJ, Haukaas SA, Akslen LA. A switch from E-cadherin to N-cadherin expression indicates epithelial to mes-enchymal transition and is of strong and independent importance for the progress of prostate cancer. Clin Cancer Res 2007, 13 : 7003 7011.